We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APOG icon
2626
Apogee Enterprises
APOG
$888M
$76K ﹤0.01%
2,007
-8,429
-81% -$338K
CAL icon
2627
Caleres
CAL
$460M
$76K ﹤0.01%
3,429
-3,968
-54% -$95.7K
CNI icon
2628
Canadian National Railway
CNI
$76.2B
$76K ﹤0.01%
655
-11,294
-95% -$1.25M
EFSC icon
2629
Enterprise Financial Services Corp
EFSC
$2.4B
$76K ﹤0.01%
1,684
-898
-35% -$40.2K
ONIT
2630
Onity Group
ONIT
$324M
$76K ﹤0.01%
2,692
+2,457
+1,046% +$67.9K
NVTA
2631
DELISTED
Invitae Corporation
NVTA
$76K ﹤0.01%
2,667
-3,105
-54% -$91K
LDL
2632
DELISTED
Lydall, Inc.
LDL
$76K ﹤0.01%
1,219
-643
-35% -$39.6K
ACIU icon
2633
AC Immune
ACIU
$261M
$75K ﹤0.01%
11,191
+8,972
+404% +$64.2K
ALTO icon
2634
Alto Ingredients
ALTO
$320M
$75K ﹤0.01%
15,120
+13,493
+829% +$68K
CRK icon
2635
Comstock Resources
CRK
$4.15B
$75K ﹤0.01%
7,257
+3,521
+94% +$23.9K
MRVI icon
2636
Maravai LifeSciences
MRVI
$863M
$75K ﹤0.01%
1,525
-2,020
-57% -$98.5K
NKTX icon
2637
Nkarta
NKTX
$170M
$75K ﹤0.01%
2,708
+913
+51% +$28.9K
PDM
2638
Piedmont Realty Trust
PDM
$1.18B
$75K ﹤0.01%
4,352
-1,694
-28% -$30.8K
PSEC icon
2639
Prospect Capital
PSEC
$1.15B
$75K ﹤0.01%
9,726
+3,107
+47% +$25K
RGS icon
2640
Regis Corp
RGS
$67.5M
$75K ﹤0.01%
1,077
+935
+658% +$123K
SHLS icon
2641
Shoals Technologies Group
SHLS
$1.46B
$75K ﹤0.01%
2,692
-6,501
-71% -$202K
STEP icon
2642
StepStone Group
STEP
$3.97B
$75K ﹤0.01%
1,746
+600
+52% +$26.5K
TRVG
2643
trivago
TRVG
$370M
$75K ﹤0.01%
6,092
+5,369
+743% +$74.6K
TS icon
2644
Tenaris
TS
$26.9B
$75K ﹤0.01%
3,548
+3,190
+891% +$64.8K
TUYA
2645
Tuya Inc
TUYA
$1.07B
$75K ﹤0.01%
8,248
-5,174
-39% -$79.6K
PETQ
2646
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$75K ﹤0.01%
2,991
+1,674
+127% +$50.4K
SDC
2647
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$75K ﹤0.01%
+14,210
New +$88.2K
GDEV
2648
DELISTED
Nexters Inc. Ordinary Shares
GDEV
$75K ﹤0.01%
+11,370
New +$95.5K
ALEX
2649
DELISTED
Alexander & Baldwin
ALEX
$74K ﹤0.01%
3,177
+231
+8% +$4.74K
AMRN
2650
Amarin Corp
AMRN
$293M
$74K ﹤0.01%
731
-616
-46% -$60.5K

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.